Last updated: 2026-09-30 22:11:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Stryker Corporation (SYK) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $275,54, with a market capitalization of $105,60B and a P/E ratio of 28,67. Over the past 52 weeks, its price has ranged from $267,00 to $392,55. This page covers its latest market performance, valuation, price trends and company information.
$105,60B | |
$276,26 | |
$406,19 | |
$30,82 | |
$278,77 | |
2,02M | |
2,62M | |
28,67 | |
$392,55 | |
$267,00 | |
1,23% | |
-- |
Stryker Corporation (SYK) is trading at $275,01 in after-hours trading as of 2026-09-30 22:05:00, down 1,35% ($3,76) from the regular-session close of $278,77.
After-hours trading shows how investors are pricing SYK after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Stryker Corporation (SYK) moved from $274,19 to $275,54, representing a gain of 0,49% ($1,35).
The stock traded between $268,69 and $280,17 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 2,54 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 6,8%
SYK is currently trading at $275,54, placing it 6,8% of the way from its 52-week low of $267,00 to its 52-week high of $392,55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 56000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Stryker Corporation (SYK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.